Yesterday the Food and Drug Administration (FDA) approved Vraylar (cariprazine) for the treatment of...
While most current antipsychotics are effective at reducing the positive symptoms of schizophrenia, ...
An eight-week, randomized, controlled study published today in AJP in Advance has found that a 1.5 m...
The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...
